Michael Barbella, Managing Editor04.21.23
NanoVibronix, Inc. has officially launched a monthly rental program for its lead products, PainShield and UroShield.
“Patients with a valid prescription will soon be able to rent PainShield and UroShield for use in their own home on a month-to-month basis, at affordable prices, and with little ongoing commitment,” CEO Brian Murphy said. “Ultimately, we are confident that this program will be eligible for Medicare reimbursement, with disposable supplies being sold separately. Patients should also benefit from the ability to obtain these products at their own convenience via a dedicated web site. We are extremely excited to be able to expand our product offering to meet patient needs. This program is another example of our stated goal to develop sustainable and portable alternatives to medication, pain relief drugs, and medical device care.”
The company recently applied for Medicare reimbursement. We anticipate a decision on the application next month and to ‘go live’ with Medicare on Oct. 1.
Headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, NanoVibronix develops medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield, UroShield, and WoundShield, all of which are portable devices suitable for administration at home without assistance of medical professionals.
Read more: NanoVibronix Releases Interim Study Results for UroShield
“Patients with a valid prescription will soon be able to rent PainShield and UroShield for use in their own home on a month-to-month basis, at affordable prices, and with little ongoing commitment,” CEO Brian Murphy said. “Ultimately, we are confident that this program will be eligible for Medicare reimbursement, with disposable supplies being sold separately. Patients should also benefit from the ability to obtain these products at their own convenience via a dedicated web site. We are extremely excited to be able to expand our product offering to meet patient needs. This program is another example of our stated goal to develop sustainable and portable alternatives to medication, pain relief drugs, and medical device care.”
The company recently applied for Medicare reimbursement. We anticipate a decision on the application next month and to ‘go live’ with Medicare on Oct. 1.
Headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, NanoVibronix develops medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield, UroShield, and WoundShield, all of which are portable devices suitable for administration at home without assistance of medical professionals.
Read more: NanoVibronix Releases Interim Study Results for UroShield